Mark S. Livingston, an officer of Progyny, Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 2,139 shares of Progyny common stock through Fidelity Brokerage Services LLC on NASDAQ.
Key Highlights
- Proposed seller: Mark S. Livingston, identified in the filing as an officer of Progyny, Inc.
- Shares proposed for sale: 2,139 shares of Progyny common stock, with an aggregate market value of $64,170.00 as stated in the filing.
- Approximate date of sale: November 4, 2026, to be executed through Fidelity Brokerage Services LLC on NASDAQ.
- Source of shares: Three separate restricted stock vestings from the issuer on September 2, 2026 (213 shares), September 3, 2026 (1,468 shares), and September 4, 2026 (458 shares), each acquired as compensation.
- Rule 10b5-1 plan: The filing indicates a plan adoption date of May 28, 2026.
- Shares outstanding: 76,726,798 shares of common stock outstanding, according to the filing.
- Prior sales: The filing reports nothing to report under securities sold during the past 3 months.
Livingston's Proposed Sale of Progyny Common Stock Under Rule 144
According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Mark S. Livingston, an officer of Progyny, Inc. (NASDAQ:PGNY), proposed to sell 2,139 shares of the company's common stock. The filing lists an aggregate market value of $64,170.00 for the proposed sale and identifies Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the executing broker.
The filing discloses that the shares to be sold were acquired through three restricted stock vesting events, all from the issuer as compensation. Specifically, 213 shares vested on September 2, 2026, 1,468 shares vested on September 3, 2026, and 458 shares vested on September 4, 2026. The filing states that no securities of Progyny were sold by Livingston during the past three months prior to the notice date.
The Form 144 notice indicates that Livingston is relying on a Rule 10b5-1 trading plan adopted on May 28, 2026. The notice was signed by Corey Walter as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Mark Livingston. The filing was dated November 4, 2026, and Progyny's total shares of common stock outstanding were reported as 76,726,798.
What Was Disclosed
Progyny officer Mark S. Livingston filed a Form 144 on November 4, 2026, proposing to sell 2,139 shares of common stock acquired via restricted stock vestings in September 2026, with an aggregate market value of $64,170.00, under a Rule 10b5-1 plan adopted May 28, 2026.




Please wait processing your request...